期刊文献+

氧化砷对MR_2细胞耐药蛋白的调节作用

Regulative effect of arsenic trioxide on the drug-resistant protein in MR_2 cell lines
下载PDF
导出
摘要 目的 :研究氧化砷 (三氧化二砷 ,As2 O3 )对肿瘤耐药蛋白的作用。方法 :以耐维A酸 (ATRA)早幼粒白血病细胞株MR2 为研究对象 ,以非耐药早幼粒白血病细胞株NB4为对照组 ,用免疫组化法观察P 糖蛋白 (Pgp)、多药耐药相关蛋白 (MRP)的表达。结果 :MR2 细胞Pgp表达 (30 %~ 4 0 % )较NB4细胞 (10 %~ 2 0 % )明显增强 (P <0 .0 0 1) ,MR2 细胞MRP表达 (6 0 .4± 4 .0~ 6 6 .5± 4 .4 )较NB4细胞 (2 8.3± 5 .6~ 31.2± 5 .1)明显增强 (P <0 .0 0 1)。 0 .5~ 2 .0μmol/L氧化砷能显著降低MR2 细胞Pgp、MRP表达。MR2 细胞Pgp、MRP表达的降低与氧化砷作用浓度和作用时间成负相关。结论 :MR2 细胞耐药蛋白Pgp、MRP表达的下调 ,可能是氧化砷克服耐药的敏感性指标。维A酸 (ATRA)可能是Pgp、MRP的转运底物。 Purpose:To detect the action of arsenic trioxide(As 2O 3) on the expression of tumor drug-resistant protein. Methods:APL cell line MR 2 resistant to all-trans retinoic acid(ATRA) was used for in vitro studies. APL cell line NB 4 was used for control. The expressions of P-glycoprotein(Pgp), multidrug resistance protein(MRP)were determined by immunocytochemical assays. Results:The expression of Pgp was significantly higher in MR 2 cell line(30%-40%) than in NB 4 cell line(10%-20%)(P<0.001),while the expression of MRP was obviously higher in MR 2 cell line(60.4±4.0-66.5±4.4) than in NB 4 cell line(28.3±5.6-31.2±5.1) (P<0.001). 0.5-2.0 μmol/l arsenic trioxide(As 2O 3) could significantly decrease the expressions of Pgp and MRP. The decreased Pgp and MRP expressions in MR 2 cell line was adversely dose-dependent and time dependent. Conclusions:The down-regulation of Pgp and MRP might be the sensitive target of arsenic trioxide(As 2O 3) to overcome drug-resistance in MR 2 cell line. ATRA might be the base substances of Pgp and MRP transmition action.
出处 《中国癌症杂志》 CAS CSCD 2004年第4期357-359,362,共4页 China Oncology
关键词 MR2细胞株 氧化砷 P-糖蛋白 多药耐药相关蛋白 MR2 cell line arsenic trioxide P-glycoprotein mutidrug resistance protein
  • 相关文献

参考文献13

  • 1蔡循,贾培敏,石学耕,史桂英,朱新华,王龙,陈赛娟,王振义,陈竺,陈国强.氧化砷诱导维甲酸耐药早幼粒细胞白血病细胞(MR-2)凋亡的体外研究[J].中华血液学杂志,1998,19(7):339-341. 被引量:44
  • 2张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬.三氧化二砷注射液治疗72例急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(2):58-60. 被引量:476
  • 3秦叔逵,钱军,陈映霞,吴达龙,刘秀峰,马军.三氧化二砷治疗原发性肝癌获缓解1例[J].临床肿瘤学杂志,1999,4(2):51-52. 被引量:36
  • 4Shou Zx, Chen GQ, Ni JH, et al. Use of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL): Ⅱ. Clinical efficacy and pharmacokinetics in relapsed patients[J]. Blood, 1997,89(9):3354-3360. 被引量:1
  • 5Mansson E, Paul A, Lofgren C, et al. Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implication for combination chemotherapy[J].Br J Haematol, 2001,114(3):557-565. 被引量:1
  • 6Ozpolat B, Lopez-Berestein G, Mehta K. ATRA(ouble) in the treatment of acute promyelocytic leukemia[J].J Biol Regul Homeost Agent, 2001,15(2):107-122. 被引量:1
  • 7Krishnamachary N, Center MS. The MRP gene associated with a non-p-glycoprotein multidrug resistance encodes a 190 kD membrane bound glycoprotein[J].Cancer Res, 1993,53(16):3658-3661. 被引量:1
  • 8Tada Y, Wada M, Migita T, et al. Increased expression of multidrug resistance associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin[J].Int J Cancer, 2002,98(4):630-635. 被引量:1
  • 9Hsia TC, Lin CC, Wang JJ, et al. Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or mutidrug resistance-related protein expression[J].Lung,2002,180(3):173-179. 被引量:1
  • 10Bodo A,Bakos E,Szeri F,et al. The role of multidrug transporters in drug availability,metabolism and toxicity[J].Toxicol Lett,2003,11(140-141):133-143. 被引量:1

二级参考文献13

共引文献518

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部